Shanxi Dayu Biological Functions Co (BJSE:920970) Notes Receivable: ¥0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920970 Shanxi Dayu Biological Functions Co Ltd BJSE:920970
66 GF Score
Price ¥6.69
GF Value ¥7.30
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Shanxi Dayu Biological Functions Co Notes Receivable?

Shanxi Dayu Biological Functions Co BJSE:920970 66 Notes Receivable is ¥0.0 Mil as of Jun. 2026. GuruFocus rates BJSE:920970 with a GF Score™ of 66/100 and a GF Value™ of ¥7.30 (Fairly Valued). The stock has 8 warning signs investors should review.

Shanxi Dayu Biological Functions Co's Notes Receivable for the quarter that ended in Jun. 2026 was ¥0.0 Mil.

Shanxi Dayu Biological Functions Co Notes Receivable Related Terms

Shanxi Dayu Biological Functions Co Notes Receivable Historical Data

* Premium members only.

The historical data trend for Shanxi Dayu Biological Functions Co's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanxi Dayu Biological Functions Co Notes Receivable Chart

Shanxi Dayu Biological Functions Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Shanxi Dayu Biological Functions Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BJSE:920970
66GF Score
Shanxi Dayu Biological Functions Co Ltd BJSE:920970
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanxi Dayu Biological Functions Co Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ¥0.0 Mil mean?
Shanxi Dayu Biological Functions Co (BJSE:920970) has a Notes Receivable of ¥0.0 Mil as of Jun. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Shanxi Dayu Biological Functions Co and its competitors.
Is Shanxi Dayu Biological Functions Co's Notes Receivable too high?
Shanxi Dayu Biological Functions Co's current Notes Receivable is ¥0.0 Mil. Overall, Shanxi Dayu Biological Functions Co has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanxi Dayu Biological Functions Co's Notes Receivable compare to VRTX and REGN?
Shanxi Dayu Biological Functions Co's Notes Receivable of ¥0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Shanxi Dayu Biological Functions Co and its competitors. Shanxi Dayu Biological Functions Co's current Notes Receivable is ¥0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanxi Dayu Biological Functions Co stock overvalued right now?
Based on GuruFocus' analysis, Shanxi Dayu Biological Functions Co (BJSE:920970) is currently considered Fairly Valued. The stock's GF Value™ is ¥7.30, compared to a current price of ¥6.69 — trading 8.4% below its estimated fair value. The current Notes Receivable is ¥0.0 Mil. Shanxi Dayu Biological Functions Co's overall GF Score™ is 66/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Shanxi Dayu Biological Functions Co (BJSE:920970), the current Notes Receivable is ¥0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanxi Dayu Biological Functions Co (BJSE:920970) Overvalued in 2026?

Based on GuruFocus' analysis, Shanxi Dayu Biological Functions Co stock appears to be undervalued. The current stock price of ¥6.69 is trading 8.4% below its estimated GF Value™ of ¥7.30. GuruFocus considers Shanxi Dayu Biological Functions Co to be Fairly Valued.

Key valuation signals for BJSE:920970:

  • Notes Receivable: ¥0.0 Mil
  • GF Value™: ¥7.30 vs. price of ¥6.69 (8.4% below fair value)
  • GF Score™: 66/100 with 8 warning signs

No single metric tells the full story. See the BJSE:920970 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanxi Dayu Biological Functions Co Business Description

Address West side of Yongle South Road Development Zone, Ruicheng County, Shanxi Province, South of Lido Hotel, Yuncheng City, CHN, 044600
Shanxi Dayu Biological Functions Co Ltd engages in the research and development of bioengineering technology and product application. Its main products are probiotics, enzyme preparations, fermented traditional Chinese medicine, biological preparations, and veterinary preparations.
66GF Score

Get the complete analysis for BJSE:920970

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥6.69
Price
¥7.30
GF Value